A Phase III Trial of With Marizomib in Patients With Newly Diagnosed Glioblastoma

NCT03345095 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

749

Enrollment

NETWORK

Sponsor class

Conditions

Newly Diagnosed Glioblastoma

Interventions

DRUG: Marizomib
DRUG: Temozolomide
RADIATION: radiotherapy

Sponsor

European Organisation for Research and Treatment of Cancer - EORTC

Collaborators

[object Object]
[object Object]